Search Results - "Requena, Juan Antonio"

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics by Santos-Gallego, Carlos G., Requena-Ibanez, Juan Antonio, San Antonio, Rodolfo, Ishikawa, Kiyotake, Watanabe, Shin, Picatoste, Belen, Flores, Eduardo, Garcia-Ropero, Alvaro, Sanz, Javier, Hajjar, Roger J., Fuster, Valentin, Badimon, Juan J.

“…Empagliflozin cardiac benefits in the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients) trial cannot be…”
Get full text

Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction by Santos-Gallego, Carlos G., Requena-Ibáñez, Juan Antonio, Picatoste, Belen, Fardman, Brian, Ishikawa, Kiyotake, Mazurek, Renata, Pieper, Michael, Sartori, Samantha, Rodriguez-Capitán, Jorge, Fuster, Valentin, Badimon, Juan J.

“…SGLT2i (sodium-glucose cotransporter-2 inhibitors) improve clinical outcomes in patients with heart failure, but the mechanisms of action are not completely…”
Get full text

Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial by Requena-Ibáñez, Juan Antonio, Santos-Gallego, Carlos García, Rodriguez-Cordero, Anderly, Vargas-Delgado, Ariana Patricia, Badimón, Juan José

“…Initially considered as just anti-diabetic agents, SGLT2-i show remarkable cardiac and renal benefits independently of its hypoglycemic activity. We used the…”
Get full text

Per-Protocol Versus Intention-to-Treat in Clinical Trials: The Example of GLOBAL-LEADERS Trial by Santos-Gallego, Carlos G, Requena-Ibanez, Juan Antonio, Badimon, Juan

Get full text

Comparison of Clinical Outcomes Between Very Long Stents and Overlapping Stents for the Treatment of Diffuse Coronary Disease in Real Clinical Practice by Jurado-Román, Alfonso, Abellán-Huerta, José, Requena, Juan Antonio, Sánchez-Pérez, Ignacio, López-Lluva, María T., Maseda-Uriza, Ramón, Piqueras-Flores, Jesús, Pérez-Díaz, Pedro, Frías-García, Raquel, Lozano-Ruíz-Poveda, Fernando

“…The stent length as well as the stent overlap for the percutaneous treatment of diffuse coronary disease have been considered predictors of adverse events…”
Get full text

Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study by Requena-Ibáñez, Juan Antonio, Santos-Gallego, Carlos G, Rodriguez-Cordero, Anderly, Vargas-Delgado, Ariana P, Mancini, Donna, Sartori, Samantha, Atallah-Lajam, Farah, Giannarelli, Chiara, Macaluso, Frank, Lala, Anuradha, Sanz, Javier, Fuster, Valentin, Badimon, Juan José

“…OBJECTIVESThe goal of this study was to evaluate the effect of empagliflozin, in addition to optimal medical treatment, on epicardial adipose tissue (EAT),…”
Get full text

Una genealogía de las modernas ideologías de la práctica by De Requena Farré, Juan Antonio González

“…En el marco ideológico de la autocomprensión moderna, las relaciones entre teoría y praxis se caracterizan por cierta diferenciación funcional y por la…”
Get full text

género de la inteligencia artificial: un diálogo-editorial con ChatGPT a modo de presentación del dosier by González-de-Requena-Farré, Juan Antonio, ChatGPT

“…Un año más ―ya son siete― volvemos a la carga con nuevas propuestas de discusión e interpretación de nuestra compleja realidad mundial e hipercompleja…”
Get full text

Constitución del sujeto de la enunciación en el poema "Balada de Pablo de Rokha" de los gemidos? by Requena Cerda, Juan Antonio

“…Este artículo propone en una relectura del poema "Balada de Pablo de Rokha" de Los gemidos (1922) de Pablo de Rokha. El objetivo es encontrar huellas (signos)…”
Get full text

Constitución del sujeto de la enunciación en Escritura de Raimundo Contreras by Juan Antonio Requena Cerda

“…Este artículo propone una relectura de Escritura de Raimundo Contreras (1929) de Pablo de Rokha. El objetivo es encontrar huellas (signos) de la presencia y…”
Get full text

Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure by Santos-Gallego, Carlos G., Requena-Ibanez, Juan Antonio, San Antonio, Rodolfo, Garcia-Ropero, Alvaro, Ishikawa, Kiyotake, Watanabe, Shin, Picatoste, Belen, Vargas-Delgado, Ariana P., Flores-Umanzor, Eduardo J., Sanz, Javier, Fuster, Valentin, Badimon, Juan J.

“…The purpose of this study was to investigate the effect of empagliflozin on diastolic function in a nondiabetic heart failure with reduced ejection fraction…”
Get full text

Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection by Requena-Ibáñez, Juan Antonio, Santos-Gallego, Carlos G., Rodriguez-Cordero, Anderly, Zafar, M. Urooj, Badimon, Juan José

“…Hypoxia, via the activity of hypoxia-inducible factors (HIFs), plays a crucial role in fibrosis, inflammation, and oxidative injury, processes which are…”
Get full text

EMPAGLIFLOZIN INDUCES A MYOCARDIAL METABOLIC SHIFT FROM GLUCOSE CONSUMPTION TO KETONE METABOLISM THAT MITIGATES ADVERSE CARDIAC REMODELING AND IMPROVES MYOCARDIAL CONTRACTILITY by Santos-Gallego, Carlos G., Ibanez, Juan Antonio Requena, Antonio, Rodolfo San, Ishikawa, Kiyotake, Watanabe, Shin, Picatoste Botija, Maria Belen, Salvo, Angel Javier Sanz, Hajjar, Roger, Fuster, Valentin, Badimon, Juan

“…Given that EMPA causes mild, persistent hyperketonemia, we hypothesized that cardiac benefits of EMPA are due to a shift in myocardial fuel metabolism away…”
Get full text

Not only how much, but also how to, when measuring epicardial adipose tissue by Requena-Ibáñez, Juan Antonio, Santos-Gallego, Carlos García, Rodriguez Cordero, Anderly José, Fardman, Brian, Sartori, Samantha, Sanz, Javier, Fuster, Valentin, Badimon, Juan José

“…Epicardial Adipose Tissue (EAT) is drawing increasing attention. As a quantifiable, modifiable, and potentially new cardiovascular therapeutic target, its…”
Get full text

Dual SGLT1 and SGLT2 inhibition: more than the sum of its parts by Sánchez-Muñoz, Enrique, Requena-Ibáñez, Juan Antonio, Badimón, Juan José

Get full text

La condición intertextual en las citas de los artículos de investigación de psicología by González de Requena, Juan Antonio, Andana, Carolina, Duhart, Claudio

“…Este artículo pretende poner de manifiesto las principales formas, funciones y tipos de fuente de la citación en dos revistas de Psicología chilenas. Se…”
Get full text

Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes by Pérez, Maeve Soto, Rodríguez-Capitán, Jorge, Requena-Ibáñez, Juan Antonio, Santos-Gallego, Carlos G, Urooj Zafar, M, Escolar, Ginés, Mancini, Donna, Mitter, Sumeet, Lam, David, Contreras, Johanna P, Fergus, Icilma, Atallah-Lajam, Farah, Abascal, Vivian, Lala, Anu, Moreno, Pedro, Moss, Noah, Lerakis, Stamatios, Sanz, Javier, Fuster, Valentin, Badimon, Juan José

“…Heart failure with preserved ejection fraction (HFpEF) is now the most common form of heart failure (HF). This syndrome is associated with an elevated…”
Get full text

Denominaciones de la nación en el discurso político chileno (1818-1989) by González de Requena, Juan Antonio

“…Este estudio pretende describir las transformaciones del léxico de identificación colectiva en Chile a través distintas expresiones del discurso político:…”
Get full text

SGLT2i in heart failure: can their benefits be expanded across the entire spectrum of ejection fraction? by Requena-Ibáñez, Juan Antonio, Santos-Gallego, Carlos G., Badimón, Juan José

“…The publication of the EMPEROR-Preserved trial and data on the benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with heart failure…”
Get full text

De necios a idiotas. Transformaciones discursivas del léxico de menosprecio intelectual by Antonio González de Requena Farré, Juan

“…Aunque existen valiosos ensayos y estudios en ciencias sociales sobre la estupidez humana, las diferentes formas de falta de inteligencia se conciben mejor…”
Get full text